CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 56 filers reported holding CABALETTA BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,461,196 | +65.1% | 96,005 | +40.1% | 0.00% | – |
| Q2 2023 | $884,968 | +961.8% | 68,549 | +580.2% | 0.00% | – |
| Q1 2023 | $83,345 | -10.6% | 10,078 | 0.0% | 0.00% | – |
| Q4 2022 | $93,222 | -74.1% | 10,078 | -68.9% | 0.00% | – |
| Q1 2021 | $360,000 | -11.1% | 32,390 | 0.0% | 0.00% | – |
| Q4 2020 | $405,000 | +21.6% | 32,390 | +5.6% | 0.00% | – |
| Q3 2020 | $333,000 | -8.3% | 30,674 | -5.6% | 0.00% | – |
| Q2 2020 | $363,000 | +166.9% | 32,503 | +74.8% | 0.00% | – |
| Q1 2020 | $136,000 | -30.3% | 18,598 | +33.8% | 0.00% | – |
| Q4 2019 | $195,000 | – | 13,898 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 2,064,263 | $4,190,000 | 0.92% |
| Kynam Capital Management, LP | 616,125 | $1,251,000 | 0.41% |
| Ikarian Capital, LLC | 1,020,070 | $2,070,000 | 0.27% |
| Cormorant Asset Management, LP | 1,154,424 | $2,343,000 | 0.18% |
| Ikarian Capital, LLC | 449,000 | $912,000 | 0.12% |
| HARBOR CAPITAL ADVISORS, INC. | 119,315 | $242,000 | 0.11% |
| Boxer Capital, LLC | 540,000 | $1,096,000 | 0.06% |
| SAMLYN CAPITAL, LLC | 1,768,083 | $3,589,000 | 0.05% |
| Redmile Group, LLC | 696,377 | $1,414,000 | 0.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 464,252 | $942,000 | 0.02% |